Clinical Trials Browser

Completed × Multiple Myeloma × Dasatinib × Clear all

NCT00560391 2016-08-04

Dasatinib in Combination With Revlimid (and Dexamethasone)

Phase 1 Completed

35 enrolled 18 charts

Multiple Myeloma